Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00133354
Status:
COMPLETED
Last Update Posted:
2011-10-12
First Post:
2005-08-19
Brief Title:
Arimidex Multicenter Trial in Growth Hormone GH Deficient Boys
Sponsor:
Nemours Childrens Clinic
Organization:
Nemours Childrens Clinic
Study Overview
Official Title:
Double-blind Trial Investigating the Safety and Efficacy of the Inhibitor Anastrozole ARIMIDEX in Delaying Epiphyseal Fusion and Increasing Height Potential of Adolescent Males With Growth Hormone GH Deficiency
Status:
COMPLETED
Status Verified Date:
2011-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to see if Arimidex an aromatase inhibitor can delay epiphyseal fusion and increase predicted adult height in boys who are growth hormone deficient in puberty and who are taking growth hormone This is a double blind placebo controlled 3 year trial
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 23381 | None | None | None |
| M2372s | None | None | None |